by rss feed | Sep 9, 2026 | CBER Director, FDA, News Feeds
Karim Mikhail, acting CBER director, has just been named the permanent branch leader. What might this mean for the cell and gene therapy field? Karim Mikhail is permanent CBER director, unusual background Most people in the field want more stability and logic-based...
